Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
Abdulmaged M. Traish, Karim Sultan Haider, Gheorghe Doros, et al.
Hormone Molecular Biology and Clinical Investigation (2017) Vol. 30, Iss. 3
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Post-finasteride syndrome: a surmountable challenge for clinicians
Abdulmaged M. Traish
Fertility and Sterility (2020) Vol. 113, Iss. 1, pp. 21-50
Open Access | Times Cited: 82
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
Li Wei, Edward Chia‐Cheng Lai, Yea-Huei Kao-Yang, et al.
BMJ (2019), pp. l1204-l1204
Open Access | Times Cited: 68
Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
Abdulmaged M. Traish
The World Journal of Men s Health (2020) Vol. 38, Iss. 3, pp. 323-323
Open Access | Times Cited: 40
Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
Abdulmaged M. Traish
Advances in experimental medicine and biology (2017), pp. 473-526
Closed Access | Times Cited: 39
Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer
Philipp Gild, Alexander P. Cole, Anna Krasnova, et al.
The Journal of Urology (2018) Vol. 200, Iss. 3, pp. 573-581
Closed Access | Times Cited: 36
Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
Zhongbao Zhou, Yuanshan Cui, Jitao Wu, et al.
BMC Urology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 32
The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis
Yao Li, Jie Ma, Xin-Hua Qin, et al.
Translational Andrology and Urology (2022) Vol. 11, Iss. 3, pp. 313-324
Open Access | Times Cited: 13
Erectile Dysfunction and Lower Urinary Tract Symptoms
Cosimo De Nunzio, Riccardo Lombardo, Giorgia Tema, et al.
Current Urology Reports (2018) Vol. 19, Iss. 8
Closed Access | Times Cited: 23
[Translated article] Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venererology (AEDV)
Sérgio Vañó-Galván, P. Fernandez-Crehuet, G. Garnacho, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 4, pp. T347-T355
Open Access | Times Cited: 2
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients
Renjie Jin, Connor M. Forbes, Nicole L. Miller, et al.
The Prostate (2022) Vol. 82, Iss. 14, pp. 1378-1388
Open Access | Times Cited: 8
Long-term Consequences of Medical Therapy for Benign Prostatic Hyperplasia.
Eric Bortnick, Vannita Simma‐Chiang, Steven A. Kaplan
PubMed (2019) Vol. 21, Iss. 4, pp. 154-157
Closed Access | Times Cited: 13
Oxidised low‐density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia
George A. Asare, Emmanunella Owusu‐Boateng, Bernice Asiedu, et al.
Andrologia (2019) Vol. 51, Iss. 8
Open Access | Times Cited: 12
Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
Nantia Othonos, Thomas Marjot, Conor Woods, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 9, pp. e3316-e3328
Open Access | Times Cited: 12
The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies
Nikolaos Nikolaou, Leanne Hodson, Jeremy Tomlinson
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 207, pp. 105808-105808
Closed Access | Times Cited: 11
The plasma proteome of plant-based diets: analyses of 1463 proteins in 50,000 people
Tammy Y. N. Tong, Karl Smith-Byrne, Keren Papier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología
Sérgio Vañó-Galván, Pablo Fernández‐Crehuet, G. Garnacho, et al.
Actas Dermo-Sifiliográficas (2023) Vol. 115, Iss. 4, pp. 347-355
Open Access | Times Cited: 4
Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
Roberto Frau, Marco Bortolato
Neuropharmacology (2018) Vol. 147, pp. 55-65
Closed Access | Times Cited: 12
Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta‑analysis of randomized controlled trials
Zhongbao Zhou, Yuanshan Cui, Jitao Wu, et al.
Experimental and Therapeutic Medicine (2020) Vol. 20, Iss. 2, pp. 1566-1574
Open Access | Times Cited: 11
Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
Abdulmaged M. Traish, Yonah Krakowsky, Gheorghe Doros, et al.
Sexual Medicine Reviews (2018) Vol. 7, Iss. 1, pp. 95-114
Closed Access | Times Cited: 9
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis
Chengquan Ma, Jianzhong Zhang, Zhonglin Cai, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-8
Open Access | Times Cited: 8
The association of new-onset diabetes mellitus and medical therapy for benign prostatic hyperplasia: A population-based study
Jeannette Johnstone, Avril Lusty, Mina Tohidi, et al.
Canadian Urological Association Journal (2021) Vol. 15, Iss. 8, pp. 240-6
Open Access | Times Cited: 7
Effect of tadalafil on penile nitric oxide synthase and corporal smooth muscle in rats under dutasteride treatment
Abdullah Gül, Serdar Altınay, Levent Kabasakal, et al.
The Aging Male (2020) Vol. 23, Iss. 2, pp. 161-167
Closed Access | Times Cited: 6
Type 2 diabetes mellitus is more commonly well controlled in younger men compared to older men
Mehmet Zahid Koçak, Gülali Aktaş, Tuba Taslamacıoğlu Duman, et al.
The Aging Male (2019) Vol. 23, Iss. 5, pp. 906-910
Closed Access | Times Cited: 5
Ameliorative effect of morin on dutasteride-tamsulosin-induced testicular oxidative stress in rat
Ebenezer Tunde Olayinka, Kayode Ezekiel Adewole
Journal of Complementary and Integrative Medicine (2020) Vol. 18, Iss. 2, pp. 327-337
Closed Access | Times Cited: 5
Thermobalancing Therapy® should be the First-Line Treatment for Kidney Stones and Benign Prostatic Hyperplasia, Discussions at the Medical Conferences
Simon Allen
ARC Journal of Urology (2017) Vol. 2, Iss. 3
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top